A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs A Ritter, J Cameron Drug and alcohol review 25 (6), 611-624, 2006 | 441 | 2006 |
The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS) J Ross, M Teesson, S Darke, M Lynskey, R Ali, A Ritter, R Cooke Drug and alcohol review 24 (5), 411-418, 2005 | 307 | 2005 |
How do drug policy makers access research evidence? A Ritter International Journal of Drug Policy 20 (1), 70-75, 2009 | 206 | 2009 |
Producing the ‘problem of drugs’: A cross national-comparison of ‘recovery’discourse in two Australian and British reports K Lancaster, K Duke, A Ritter International Journal of Drug Policy 26 (7), 617-625, 2015 | 183 | 2015 |
One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS) M Teesson, J Ross, S Darke, M Lynskey, R Ali, A Ritter, R Cooke Drug and alcohol dependence 83 (2), 174-180, 2006 | 181 | 2006 |
The reliability and internal validity of the Wisconsin Card Sorting Test SC Bowden, KS Fowler, RC Bell, G Whelan, CC Clifford, AJ Ritter, ... Neuropsychological Rehabilitation 8 (3), 243-254, 1998 | 153 | 1998 |
Studying illicit drug markets: Disciplinary contributions A Ritter International Journal of Drug Policy 17 (6), 453-463, 2006 | 141 | 2006 |
Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985–2010 K Lancaster, A Ritter International Journal of Drug Policy 25 (1), 81-87, 2014 | 139 | 2014 |
Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS) S Darke, J Ross, M Teesson, R Ali, R Cooke, A Ritter, M Lynskey Journal of substance abuse treatment 28 (3), 255-263, 2005 | 128 | 2005 |
LAAM maintenance vs methadone maintenance for heroin dependence NC Clark, N Lintzeris, A Gijsbers, G Whelan, A Dunlop, A Ritter, WW Ling, ... Cochrane Database of Systematic Reviews 2010 (1), 1996 | 128 | 1996 |
Serious adverse events in the Australian national evaluation of pharmacotherapies for opioid dependence (NEPOD) E Digiusto, A Shakeshaft, A Ritter, S O'Brien, RP Mattick, ... Addiction 99 (4), 450-460, 2004 | 127 | 2004 |
Take-home naloxone for the emergency interim management of opioid overdose: the public health application of an emergency medicine J Strang, R McDonald, G Campbell, L Degenhardt, S Nielsen, A Ritter, ... Drugs 79, 1395-1418, 2019 | 113 | 2019 |
Pill testing or drug checking in Australia: acceptability of service design features MJ Barratt, R Bruno, N Ezard, A Ritter Drug and alcohol review 37 (2), 226-236, 2018 | 108 | 2018 |
A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting AH Harris, E Gospodarevskaya, AJ Ritter Pharmacoeconomics 23, 77-91, 2005 | 107 | 2005 |
Global review of drug checking services operating in 2017 MJ Barratt, M Kowalski, LJ Maier, A Ritter Drug policy modelling program bulletin 24, 1-23, 2018 | 106 | 2018 |
The ethics of paying drug users who participate in research: A review and practical recommendations CL Fry, W Hall, A Ritter, R Jenkinson Journal of Empirical Research on Human Research Ethics 1 (4), 21-35, 2006 | 104 | 2006 |
Paying research participants: a study of current practices in Australia CL Fry, A Ritter, S Baldwin, KJ Bowen, P Gardiner, T Holt, R Jenkinson, ... Journal of medical ethics 31 (9), 542-547, 2005 | 101 | 2005 |
Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose AJ Ritter Australian & New Zealand Journal of Psychiatry 36 (2), 224-228, 2002 | 100 | 2002 |
The influence of the therapeutic relationship in treatment for alcohol dependency A Ritter, S Bowden, T Murray, P Ross, J Greeley, J Pead Drug and alcohol review 21 (3), 261-268, 2002 | 97 | 2002 |
The deterrent effects of Australian street-level drug law enforcement on illicit drug offending at outdoor music festivals CE Hughes, V Moxham-Hall, A Ritter, D Weatherburn, R MacCoun International Journal of Drug Policy 41, 91-100, 2017 | 95 | 2017 |